JP2015530404A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015530404A5 JP2015530404A5 JP2015532965A JP2015532965A JP2015530404A5 JP 2015530404 A5 JP2015530404 A5 JP 2015530404A5 JP 2015532965 A JP2015532965 A JP 2015532965A JP 2015532965 A JP2015532965 A JP 2015532965A JP 2015530404 A5 JP2015530404 A5 JP 2015530404A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- active ingredient
- conjugate
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 239000004480 active ingredient Substances 0.000 claims 13
- 239000002872 contrast media Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 239000005090 green fluorescent protein Substances 0.000 claims 2
- 235000013402 health food Nutrition 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 claims 1
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000005298 paramagnetic effect Effects 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120104144 | 2012-09-19 | ||
| KR10-2012-0104144 | 2012-09-19 | ||
| KR10-2012-0109216 | 2012-09-28 | ||
| KR20120109216 | 2012-09-28 | ||
| KR20130017046 | 2013-02-18 | ||
| KR10-2013-0017169 | 2013-02-18 | ||
| KR10-2013-0017046 | 2013-02-18 | ||
| KR20130017169 | 2013-02-18 | ||
| PCT/KR2013/008445 WO2014046481A1 (ko) | 2012-09-19 | 2013-09-17 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015530404A JP2015530404A (ja) | 2015-10-15 |
| JP2015530404A5 true JP2015530404A5 (enExample) | 2016-11-10 |
| JP6510410B2 JP6510410B2 (ja) | 2019-05-08 |
Family
ID=50341702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015532965A Active JP6510410B2 (ja) | 2012-09-19 | 2013-09-17 | 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9631184B2 (enExample) |
| EP (1) | EP2899199B1 (enExample) |
| JP (1) | JP6510410B2 (enExample) |
| KR (1) | KR102201430B1 (enExample) |
| CN (3) | CN110028554B (enExample) |
| ES (1) | ES2743919T3 (enExample) |
| TW (1) | TWI598441B (enExample) |
| WO (1) | WO2014046481A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102578891B1 (ko) | 2012-05-11 | 2023-09-15 | 주식회사 젬백스앤카엘 | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 |
| EP2875826B1 (en) | 2012-05-11 | 2017-08-23 | KAEL-GemVax Co.,Ltd | Composition for preventing or treating sepsis |
| ES2981865T3 (es) | 2012-07-11 | 2024-10-10 | Gemvax & Kael Co Ltd | Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo |
| US20150125438A1 (en) | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
| KR102201429B1 (ko) | 2012-09-19 | 2021-01-12 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
| TWI655204B (zh) | 2012-09-19 | 2019-04-01 | 韓商傑姆維克斯＆凱爾有限公司 | 穿膜胜肽以及包含該胜肽之共軛物及組成物(三) |
| WO2014171792A1 (ko) | 2013-04-19 | 2014-10-23 | 주식회사 카엘젬백스 | 허혈성 손상 치료 및 예방용 조성물 |
| CN105535931A (zh) | 2013-06-07 | 2016-05-04 | 凯尔杰姆维克斯有限公司 | 在癌症免疫疗法中有用的生物标记 |
| TWI539960B (zh) | 2013-06-21 | 2016-07-01 | 凱爾傑姆維克斯有限公司 | 激素分泌調節劑、包括其的組成物以及其用途 |
| US9757473B2 (en) * | 2013-07-12 | 2017-09-12 | Gemvax & Kael Co., Ltd. | Cell-penetrating peptide and conjugate comprising same |
| CN105899224B (zh) | 2013-10-23 | 2019-12-13 | 珍白斯凯尔有限公司 | 用于治疗和预防良性前列腺增生的组合物 |
| KR102494803B1 (ko) | 2013-11-22 | 2023-02-06 | 주식회사 젬백스앤카엘 | 혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물 |
| ES2809251T3 (es) | 2013-12-17 | 2021-03-03 | Gemvax & Kael Co Ltd | Composición para tratar cáncer de próstata |
| EP3130345B9 (en) | 2014-04-11 | 2022-05-04 | Gemvax & Kael Co., Ltd. | Peptide having fibrosis inhibitory activity and composition containing same |
| ES2962532T3 (es) | 2014-04-30 | 2024-03-19 | Gemvax & Kael Co Ltd | Composición para el trasplante de órganos, tejidos o células, kit y procedimiento de trasplante |
| KR102413243B1 (ko) | 2014-12-23 | 2022-06-27 | 주식회사 젬백스앤카엘 | 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물 |
| EP3263122B1 (en) | 2015-02-27 | 2020-05-06 | Gemvax & Kael Co., Ltd. | Peptide for preventing hearing loss, and composition comprising same |
| KR20250073577A (ko) | 2015-05-26 | 2025-05-27 | 주식회사 젬백스앤카엘 | 신규 펩티드 및 이를 포함한 조성물 |
| WO2017003267A1 (ko) | 2015-07-02 | 2017-01-05 | 주식회사 젬백스앤카엘 | 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
| WO2017078440A1 (ko) * | 2015-11-03 | 2017-05-11 | 주식회사 젬백스앤카엘 | 신경세포 손실 예방 및 재생 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
| KR101661912B1 (ko) * | 2016-01-29 | 2016-10-04 | (주)넥스젠바이오텍 | 녹색형광단백질-인간 상피세포재생인자 융합단백질을 유효성분으로 포함하는 주름 개선 및 항노화 화장료 조성물 |
| WO2017176087A1 (ko) | 2016-04-07 | 2017-10-12 | 주식회사 젬백스앤카엘 | 텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
| EP3443001B1 (en) | 2016-04-11 | 2025-04-30 | Obsidian Therapeutics, Inc. | REGULATED BIOCIRCUIT SYSTEMS |
| CN110913954A (zh) | 2017-03-03 | 2020-03-24 | 黑曜石疗法公司 | 免疫疗法的组合物和方法 |
| CN110831961B (zh) | 2017-03-03 | 2024-01-02 | 黑曜石疗法公司 | 用于免疫疗法的cd19组合物和方法 |
| US20220403001A1 (en) | 2018-06-12 | 2022-12-22 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
| WO2020086742A1 (en) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
| WO2021046451A1 (en) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
| US20230181681A1 (en) * | 2020-05-08 | 2023-06-15 | Industry Academic Cooperation Foundation, Hallym University | Peptide for suppressing coronavirus and use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610839B1 (en) * | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
| CN1254376A (zh) * | 1996-10-01 | 2000-05-24 | 杰龙公司 | 端粒酶逆转录酶 |
| US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| GB0112342D0 (en) * | 2001-05-21 | 2001-07-11 | Norsk Hydro As | Polypeptides |
| AU2002363231A1 (en) * | 2001-10-29 | 2003-05-12 | Baylor College Of Medicine | Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen |
| US7294708B2 (en) * | 2002-05-31 | 2007-11-13 | Beijing Institute Of Biotechnology | Telomerase reverse transcriptase fragments and uses thereof |
| WO2007069068A2 (en) * | 2005-12-16 | 2007-06-21 | Diatos | Cell penetrating peptide conjugates for delivering nucleic acids into cells |
| WO2007097561A1 (en) | 2006-02-20 | 2007-08-30 | Ewha University - Industry Collaboration Foundation | Peptide having cell membrane penetrating activity |
| AU2008211854C1 (en) * | 2007-01-29 | 2014-01-23 | Procell Therapeutics Inc. | Novel macromolecule transduction domains and methods for identification and uses thereof |
| EP1994942A1 (en) * | 2007-05-25 | 2008-11-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical compositions comprising telomerase, and uses thereof |
| DK2310044T3 (en) * | 2008-06-16 | 2016-12-12 | Mediolanum Farm S P A | Antitumor IMMUNOTHERAPY |
| ES2334315B1 (es) | 2008-07-29 | 2011-02-28 | Universitat Pompeu Fabra | Peptidos con capacidad de penetracion celular y sus usos. |
| US20110318380A1 (en) * | 2008-10-01 | 2011-12-29 | Dako Denmark A/S | MHC Multimers in Cancer Vaccines and Immune Monitoring |
| KR101169030B1 (ko) | 2009-01-21 | 2012-07-26 | 애니젠 주식회사 | 신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템 |
| WO2010134537A1 (ja) | 2009-05-20 | 2010-11-25 | 東レ株式会社 | 細胞膜透過性ペプチド |
| EP3581649A1 (en) | 2010-02-16 | 2019-12-18 | Ultimovacs ASA | Polypeptides |
| KR101263212B1 (ko) | 2010-05-28 | 2013-05-10 | 성신여자대학교 산학협력단 | 신규한 세포막 투과성 펩타이드 및 그의 용도 |
| WO2011150494A1 (en) * | 2010-05-30 | 2011-12-08 | The Governing Council Of The University Of Toronto | Mitochondrial penetrating peptides as carriers for anticancer compounds |
| KR101348284B1 (ko) | 2010-09-09 | 2014-01-03 | 주식회사 나이벡 | 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도 |
| KR102578891B1 (ko) | 2012-05-11 | 2023-09-15 | 주식회사 젬백스앤카엘 | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 |
| ES2981865T3 (es) | 2012-07-11 | 2024-10-10 | Gemvax & Kael Co Ltd | Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo |
| KR102201429B1 (ko) | 2012-09-19 | 2021-01-12 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
| TWI655204B (zh) | 2012-09-19 | 2019-04-01 | 韓商傑姆維克斯＆凱爾有限公司 | 穿膜胜肽以及包含該胜肽之共軛物及組成物(三) |
| KR101778244B1 (ko) * | 2014-05-13 | 2017-09-26 | 한양대학교 산학협력단 | 세포 투과성 펩티드 및 이를 이용한 생물학적 활성 물질의 전달방법 |
-
2013
- 2013-09-17 WO PCT/KR2013/008445 patent/WO2014046481A1/ko not_active Ceased
- 2013-09-17 ES ES13839102T patent/ES2743919T3/es active Active
- 2013-09-17 US US14/429,641 patent/US9631184B2/en active Active
- 2013-09-17 CN CN201910048425.2A patent/CN110028554B/zh active Active
- 2013-09-17 JP JP2015532965A patent/JP6510410B2/ja active Active
- 2013-09-17 CN CN201910049089.3A patent/CN110064056B/zh active Active
- 2013-09-17 EP EP13839102.4A patent/EP2899199B1/en active Active
- 2013-09-17 TW TW102133733A patent/TWI598441B/zh active
- 2013-09-17 CN CN201380057722.4A patent/CN104768967B/zh active Active
- 2013-09-17 KR KR1020157009510A patent/KR102201430B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016500648A5 (enExample) | ||
| JP2016500513A5 (enExample) | ||
| JP2015530358A5 (enExample) | ||
| Kang et al. | A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma | |
| JP2024073589A (ja) | エキソソームを標的化する方法 | |
| JP6789823B2 (ja) | 両末端ｐｅｇ化インテグリン結合性ペプチドおよびその使用方法 | |
| JP2011037872A5 (enExample) | ||
| JP2017538401A5 (enExample) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa | |
| JP2009292810A5 (enExample) | ||
| JP2014221801A5 (enExample) | ||
| JP2015522264A5 (enExample) | ||
| CN102264755A (zh) | 靶向vegfr-1/nrp-1的肽 | |
| JP2009521206A5 (enExample) | ||
| JP2014526881A5 (enExample) | ||
| RU2015102027A (ru) | Проникающие в клетку пептиды и способы идентификации проникающих в клетку пептидов | |
| RU2017114673A (ru) | Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение | |
| JP2012529293A5 (enExample) | ||
| JP2013535445A5 (enExample) | ||
| JP2016523558A5 (enExample) | ||
| CN103788211B (zh) | 双功能肽、所述双功能肽与核酸分子形成的复合物以及治疗肿瘤的药物组合物 | |
| JP2016526021A5 (enExample) | ||
| Wong et al. | The therapeutic anticancer potential of marine-derived bioactive peptides: a highlight on pardaxin | |
| US20170000867A1 (en) | Vaccine compositions and methods for restoring nkg2d pathway function against cancers | |
| US20180244724A1 (en) | Polypeptide compound and preparation method and use thereof |